Gubra A/S announced that at its extraordinary general meeting held on November 1, 2023, approved the election of Monika Leesl and Astrid Haug as new members to the board of directors. The board of directors hereafter consists of Jacob Jelsing (chair), Alexander Thomas Martensen-Larsen (deputy chair), Henriette Rosenquist, Arndt Justus Georg Schottelius, Monika Lessl and Astrid Haug. Monika Lessl is an internationally experienced pharma executive with more than 15 years R&D leadership experience from Bayer AG (Germany).

Monika is currently Executive Director of Bayer Foundation, and Senior Vice President; Head of Corporate R&D and Social Innovation Bayer AG. She holds a PhD in Biochemistry from the Max Planck Institute for Molecular Genetics in Berlin. In her former role as Head of Innovation Strategy she developed and led Bayer's Innovation Agenda to strengthen Bayer's Innovation capabilities and foster new business models.

As Head of External Innovation Therapeutics at Bayer's pharmaceutical division she was responsible for creating the external innovation strategy and leading global partnering activities. Besides her executive role, she is a Board member of the Futurium, and acts as a jury member of the European Innovation Council and the German Ministry of Science and Education. Astrid Haug is an independent consultant in Astrid Haug ApS bureau, consulting private companies, organisations, start-ups and funds on digital strategy, social media, innovation, and green impact communication.

She is the author of six books and recognised as an expert on radio and television debates and other media covering these topics. Astrid holds a cand. mag.

In Media Sciences and is Member of Faculty at CBS/Børsen Executive Board education and member of the Digital Council at the Danish Academy of Technical Sciences. Besides that, she acts as board member in UNICEF Denmark (Chair), Symbion A/S, Nørrebro Teater and in two start-ups; Re-Zip Aps and Veras ApS (Veras vintage).